<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>:: ABL, SA :: HIV Clinical Point of Care Software :: TherapyEdge®-HIV :: ViroScore® Suite :: MyView :: TherapyEdge®-PDA ::</title>
	<atom:link href="http://www.therapyedge.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.therapyedge.com</link>
	<description>TherapyEdge®</description>
	<lastBuildDate>Fri, 02 Dec 2011 14:10:02 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>TALKING HEADS: A service that fills the follow-up gap</title>
		<link>http://www.therapyedge.com/talking-heads-a-service-that-fills-the-follow-up-gap/</link>
		<comments>http://www.therapyedge.com/talking-heads-a-service-that-fills-the-follow-up-gap/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 08:12:10 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Western World]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2516</guid>
		<description><![CDATA[As World AIDS Day on Thursday approaches, Kim Hoepfl looks at an NGO that helps keep HIV-positive workers productive. More information]]></description>
		<wfw:commentRss>http://www.therapyedge.com/talking-heads-a-service-that-fills-the-follow-up-gap/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Right To Care &#8211; Data gathering and analysis</title>
		<link>http://www.therapyedge.com/therapyedge/</link>
		<comments>http://www.therapyedge.com/therapyedge/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 07:33:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[NewsWorld]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2500</guid>
		<description><![CDATA[More information]]></description>
		<wfw:commentRss>http://www.therapyedge.com/therapyedge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Advanced Biological Laboratories (ABL) / TherapyEdge INC</title>
		<link>http://www.therapyedge.com/advanced-biological-laboratories-abl-therapyedge-inc/</link>
		<comments>http://www.therapyedge.com/advanced-biological-laboratories-abl-therapyedge-inc/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 07:29:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[NewsWorld]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2496</guid>
		<description><![CDATA[Monsieur Chalom SAYADA, Manager Ronan BOULME, Manager More information]]></description>
		<wfw:commentRss>http://www.therapyedge.com/advanced-biological-laboratories-abl-therapyedge-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TherapyEdge HIV™ is a Web-based decision support system for the treatment of HIV. It forms the first release module of TherapyEdge, a knowledge-based system for the treatment of chronic diseases.</title>
		<link>http://www.therapyedge.com/therapyedge-in-the-news-around-the-world/</link>
		<comments>http://www.therapyedge.com/therapyedge-in-the-news-around-the-world/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 07:12:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[NewsWorld]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2486</guid>
		<description><![CDATA[R. Boulme, D. Gonzalez and JC. Schmit. Storing genotypic resistance data and linking to other clinical information. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004 More information]]></description>
		<wfw:commentRss>http://www.therapyedge.com/therapyedge-in-the-news-around-the-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparison of Population Genotype and Ultradeep Sequencing Results from Subjects with Virologic Failure in ARIES: Impact of Low-abundance HIV Variants on Outcome</title>
		<link>http://www.therapyedge.com/comparison-of-population-genotype-and-ultradeep-sequencing-results-from-subjects-with-virologic-failure-in-aries-impact-of-low-abundance-hiv-variants-on-outcome-2/</link>
		<comments>http://www.therapyedge.com/comparison-of-population-genotype-and-ultradeep-sequencing-results-from-subjects-with-virologic-failure-in-aries-impact-of-low-abundance-hiv-variants-on-outcome-2/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 11:59:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2222</guid>
		<description><![CDATA[September 17-20, 2011 Lisa Ross1, Kathleen Squires2, Benjamin Young3, Edwin DeJesus4, Nicholas Bellos5, Daniel Murphy6, Henry Zhao1, Brian Wine1, Joseph Horton1, Mark Shaefer7 1GlaxoSmithKline, RTP, NC, USA; 2Thomas Jefferson Univ., Philadelphia, PA,USA; 3Rocky Mountain CARES/DIDC, Denver, CO, USA; Health Connections &#8230; <a href="http://www.therapyedge.com/comparison-of-population-genotype-and-ultradeep-sequencing-results-from-subjects-with-virologic-failure-in-aries-impact-of-low-abundance-hiv-variants-on-outcome-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.therapyedge.com/comparison-of-population-genotype-and-ultradeep-sequencing-results-from-subjects-with-virologic-failure-in-aries-impact-of-low-abundance-hiv-variants-on-outcome-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pre-Therapy Detection of Transmitted Low-abundance HIV-1 Resistance Mutation-containing Variants in Antiviral-naïve Subjects and Implications for Subsequent Clinical Therapy Response</title>
		<link>http://www.therapyedge.com/pre-therapy-detection-of-transmitted-low-abundance-hiv-1-resistance-mutation-containing-variants-in-antiviral-naive-subjects-and-implications-for-subsequent-clinical-therapy-response/</link>
		<comments>http://www.therapyedge.com/pre-therapy-detection-of-transmitted-low-abundance-hiv-1-resistance-mutation-containing-variants-in-antiviral-naive-subjects-and-implications-for-subsequent-clinical-therapy-response/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 11:15:06 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2122</guid>
		<description><![CDATA[September 17-20, 2011 Lisa Ross1, Kathleen Squires2, Benjamin Young3, Edwin DeJesus4, Nicholas Bellos5, Daniel Murphy6, Henry Zhao1, Brian Wine1, Joseph Horton1, Mark Shaefer7 1GlaxoSmithKline, RTP, NC, USA; 2Thomas Jefferson Univ., Philadelphia, PA,USA; 3Rocky Mountain CARES/DIDC, Denver, CO, USA; Health Connections &#8230; <a href="http://www.therapyedge.com/pre-therapy-detection-of-transmitted-low-abundance-hiv-1-resistance-mutation-containing-variants-in-antiviral-naive-subjects-and-implications-for-subsequent-clinical-therapy-response/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.therapyedge.com/pre-therapy-detection-of-transmitted-low-abundance-hiv-1-resistance-mutation-containing-variants-in-antiviral-naive-subjects-and-implications-for-subsequent-clinical-therapy-response/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.</title>
		<link>http://www.therapyedge.com/human-immunodeficiency-virus-type-1-drug-resistance-testing-evaluation-of-a-new-ultra-deep-sequencing-based-protocol-and-comparison-with-the-trugene-hiv-1-genotyping-kit/</link>
		<comments>http://www.therapyedge.com/human-immunodeficiency-virus-type-1-drug-resistance-testing-evaluation-of-a-new-ultra-deep-sequencing-based-protocol-and-comparison-with-the-trugene-hiv-1-genotyping-kit/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 10:15:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2121</guid>
		<description><![CDATA[Aug 27, 2011 Stelzl E, Pröll J, Bizon B, Niklas N, Danzer M, Hackl C, Stabentheiner S, Gabriel C, Kessler HH. http://www.ncbi.nlm.nih.gov/pubmed/21907239]]></description>
		<wfw:commentRss>http://www.therapyedge.com/human-immunodeficiency-virus-type-1-drug-resistance-testing-evaluation-of-a-new-ultra-deep-sequencing-based-protocol-and-comparison-with-the-trugene-hiv-1-genotyping-kit/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.</title>
		<link>http://www.therapyedge.com/hiv-1-resistance-associated-mutations-after-failure-of-first-line-antiretroviral-treatment-among-children-in-resource-poor-regions-a-systematic-review/</link>
		<comments>http://www.therapyedge.com/hiv-1-resistance-associated-mutations-after-failure-of-first-line-antiretroviral-treatment-among-children-in-resource-poor-regions-a-systematic-review/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 10:15:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2120</guid>
		<description><![CDATA[Aug 25, 2011 by Kim Ce Sigaloff, Job Cj Calis, Sibyl P Geelen, Michèle Van Vugt, Tobias F Rinke De Wit http://www.ncbi.nlm.nih.gov/pubmed/21872531]]></description>
		<wfw:commentRss>http://www.therapyedge.com/hiv-1-resistance-associated-mutations-after-failure-of-first-line-antiretroviral-treatment-among-children-in-resource-poor-regions-a-systematic-review/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Analysis of co-receptor usage of circulating viral and proviral HIV genome quasispecies by ultra-deep pyrosequencing in patients candidate to CCR5 antagonist treatment.</title>
		<link>http://www.therapyedge.com/analysis-of-co-receptor-usage-of-circulating-viral-and-proviral-hiv-genome-quasispecies-by-ultra-deep-pyrosequencing-in-patients-candidate-to-ccr5-antagonist-treatment/</link>
		<comments>http://www.therapyedge.com/analysis-of-co-receptor-usage-of-circulating-viral-and-proviral-hiv-genome-quasispecies-by-ultra-deep-pyrosequencing-in-patients-candidate-to-ccr5-antagonist-treatment/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 08:15:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2141</guid>
		<description><![CDATA[May, 2011 Abbate I, Rozera G, Tommasi C, Bruselles A, Bartolini B, Chillemi G, Nicastri E, Narciso P, Ippolito G, Capobianchi MR. http://www.ncbi.nlm.nih.gov/pubmed/20731681]]></description>
		<wfw:commentRss>http://www.therapyedge.com/analysis-of-co-receptor-usage-of-circulating-viral-and-proviral-hiv-genome-quasispecies-by-ultra-deep-pyrosequencing-in-patients-candidate-to-ccr5-antagonist-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.</title>
		<link>http://www.therapyedge.com/low-frequency-hiv-1-drug-resistance-mutations-and-risk-of-nnrti-based-antiretroviral-treatment-failure-a-systematic-review-and-pooled-analysis/</link>
		<comments>http://www.therapyedge.com/low-frequency-hiv-1-drug-resistance-mutations-and-risk-of-nnrti-based-antiretroviral-treatment-failure-a-systematic-review-and-pooled-analysis/#comments</comments>
		<pubDate>Tue, 18 Oct 2011 08:00:46 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Publications]]></category>

		<guid isPermaLink="false">http://crm.therapyedge.com/?p=2118</guid>
		<description><![CDATA[Apr 6, 2011 by Jonathan Z Li, Roger Paredes, Heather J Ribaudo, Evguenia S Svarovskaia, Karin J Metzner, Michael J Kozal, Kathy Huppler Hullsiek, Melanie Balduin, Martin R Jakobsen, Anna Maria Geretti, Rodolphe Thiebaut, Lars Ostergaard, Bernard Masquelier, Jeffrey A &#8230; <a href="http://www.therapyedge.com/low-frequency-hiv-1-drug-resistance-mutations-and-risk-of-nnrti-based-antiretroviral-treatment-failure-a-systematic-review-and-pooled-analysis/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.therapyedge.com/low-frequency-hiv-1-drug-resistance-mutations-and-risk-of-nnrti-based-antiretroviral-treatment-failure-a-systematic-review-and-pooled-analysis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

